Healthtech Startups

Resolve360 offers online physiotherapy and rehabilitation through video consultations, connecting patients with qualified physiotherapists for personalized treatment plans they can follow at home. It also provides pain management, speech therapy, women's health, clinical psychology, and medical nutrition services, primarily serving patients in India and other international locations.

1 investor

Resolve helps patients navigate and reduce medical bills through expert negotiation with hospitals and billing systems. The company serves American families burdened by healthcare costs and aims to address medical debt as a leading cause of bankruptcy.

1 investor

ResolvMD is a medical billing software company founded by physicians that provides billing management and financial analytics tools for physicians in Canada. The platform automates billing processes, reduces administrative complexity, and offers peer benchmarking and AI-driven insights to help physicians optimize their practice earnings.

1 investor

RESON8 is a speech recognition engine that adapts to domain-specific vocabulary and terminology using text-based adaptation rather than audio datasets or fine-tuning. It targets regulated environments such as healthcare, offering EU-hosted infrastructure with no audio retention for use cases like streaming, voice agents, and medical transcription.

1 investor

Résonance Imagerie is a network of medical imaging centers staffed by specialized radiologists, offering diagnostic imaging services such as MRI to patients. Its centers are located across Île-de-France, Centre-Val de Loire, Hauts-de-France, and Normandie in France.

1 investor

Resonate AI is an AI dental receptionist that answers inbound calls, follows up on missed calls by text, converts website visitors via chat, and reaches out to overdue patients, booking appointments directly into a practice management system. It serves DSOs and multi-location dental groups and offers HIPAA-compliant, dental-trained AI agents with practice-specific configuration.

1 investor

ResoSight develops patent-protected technology that captures biometric data through everyday headphones and earbuds, without additional wearables or sensors. Its platform delivers health and wellness insights to consumers using devices they already own.

1 investor

Respindle develops AI-driven tools for reproductive medicine, combining clinical embryology expertise with machine learning to support IVF and reproductive technology. It serves the fertility and reproductive medicine field.

1 investor

Respira provided clinical respiratory services, sleep, home medical equipment, and home health care to patients across the Mid-Atlantic Region. The company ceased business operations as of March 9, 2018.

1 investor

Respiray manufactures a wearable personal air purifier that uses a HEPA filter to capture airborne allergens and protect individuals suffering from allergies and asthma. The device is designed as a portable, hands-free accessory that creates a protective shield of clean air around the wearer's face.

1 investor

Response Bio develops the RAMP platform, which delivers acute care diagnostic testing with lab-quality results within minutes to support rapid clinical decision-making in healthcare settings. The company serves medical teams and partners seeking to reduce diagnostic turnaround time and total cost of care.

1 investor

Response Pharmaceuticals is a clinical-stage drug developer working on RDX-002, a small-molecule iMTP inhibitor for weight management and metabolic health, including post-GLP-1 receptor agonist weight management and antipsychotic-induced weight gain. The company is advancing the candidate through Phase 2 clinical trials.

1 investor

ResQ Pharma is a pharmaceutical company developing LipidRescue (LRT), an investigational lipid-based drug therapy that is pending FDA approval. The company works on biologics development, regulatory affairs, and clinical research for its drug candidate.

1 investor

restor3d designs and manufactures patient-specific 3D-printed orthopaedic implants for musculoskeletal reconstruction, using osseointegrative biomaterials, AI-driven design, and digital health tools. Its products serve surgeons and patients across foot and ankle, knee, and hip procedures, with support for pre-surgical planning and personalized instrumentation.

1 investor

Restorsea develops clinical-grade skincare products containing Aquabeautine XL, a patented enzyme derived from salmon hatching that selectively targets dead skin cells for exfoliation and anti-aging benefits. The company serves consumers seeking prescription-level skincare results without traditional retinoid side effects.

1 investor

Resurgens Orthopaedics is a medical practice providing orthopedic care including sports medicine, joint replacement, and surgical services to patients in the Fayetteville, Georgia area and surrounding south Metro Atlanta region. The practice operates multiple facilities offering physician services, on-site MRI imaging, rehabilitation therapy, and urgent care.

1 investor

Resuscitec develops and produces extracorporeal cardiopulmonary resuscitation technology for emergency and intensive care medicine. The company serves hospitals and emergency services with CARL Technology systems for both in-hospital and out-of-hospital resuscitation applications.

1 investor

ResVent develops respiratory and critical care medical devices, including invasive and non-invasive ventilators and diagnostic equipment for hospital critical care and chronic respiratory disease management.

1 investor

Retension Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for hypertension and cardiovascular disease. The company's lead compound, RTN-001, is a tissue-targeted PDE5 inhibitor designed to treat resistant hypertension through a differentiated mechanism targeting the central pulmonary vasculature.

1 investor

Retia Medical develops advanced hemodynamic monitoring devices, including the Argos Cardiac Output Monitor, which uses proprietary algorithms to provide real-time clinical decision support for high-risk patients. The company's products support clinicians in critical care and perioperative settings.

1 investor

Reticare develops scientifically validated eye-protection products, such as screen filters and glasses, that absorb high-energy blue and green light emitted by digital screens to reduce cumulative retinal damage. The technology is based on over 20 years of research by Dr. Celia Sánchez-Ramos at the Universidad Complutense de Madrid, and the products are used by consumers ranging from children to heavy screen users across more than 30 countries.

1 investor

RetiDiag provides teleophthalmology services and visual health field operations to detect, evaluate, and monitor eye conditions, connecting clinical teams and professionals to improve access to specialized eye care. It serves health institutions such as primary care centers (CESFAM), hospitals, municipalities, and health organizations, with a focus on communities with limited access to specialized care in Chile.

1 investor

IRIS is cloud-based, camera-agnostic retinal screening software that lets healthcare providers capture, enhance, and diagnose diabetic retinopathy, with board-certified eye specialists interpreting the images. It serves hospitals, health systems, federally qualified health centers, health plans, labs, pharmacies, and health risk assessment companies to close care gaps and reduce costs.

1 investor

RetMap develops next-generation electroretinography sensors and diagnostic medical devices for screening, diagnosis, and treatment of neurodegenerative eye conditions. The company serves ophthalmologists and clinicians seeking to detect and manage retinal diseases and prevent vision loss.

1 investor